Difelikefalin Acetate Patent Expiration
Difelikefalin Acetate is Used for managing moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis. It was first introduced by Cara Therapeutics Inc
Difelikefalin Acetate Patents
Given below is the list of patents protecting Difelikefalin Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Korsuva | US10017536 | Synthetic peptide amides and dimers thereof | Nov 12, 2027 | Cara Therap |
| Korsuva | US10138270 | Synthetic peptide amides | Nov 12, 2027 | Cara Therap |
| Korsuva | US10793596 | Synthetic peptide amides | Nov 12, 2027 | Cara Therap |
| Korsuva | US7402564 | Synthetic peptide amides | Nov 12, 2027 | Cara Therap |
| Korsuva | US7713937 | Synthetic peptide amides and dimeric forms thereof | Nov 12, 2027 | Cara Therap |
| Korsuva | US7727963 | Synthetic peptide amides | Nov 12, 2027 | Cara Therap |
| Korsuva | US8217007 | Synthetic peptide amides | Nov 12, 2027 | Cara Therap |
| Korsuva | US8236766 | Uses of synthetic peptide amides | Nov 12, 2027 | Cara Therap |
| Korsuva | US8486894 | Synthetic peptide amides and dimeric forms thereof | Nov 12, 2027 | Cara Therap |
| Korsuva | US8536131 | Synthetic peptide amides and dimers thereof | Nov 12, 2027 | Cara Therap |
| Korsuva | US9334305 | Synthetic peptide amides and dimers thereof | Nov 12, 2027 | Cara Therap |
| Korsuva | US9359399 | Synthetic peptide amides | Nov 12, 2027 | Cara Therap |
Difelikefalin Acetate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List